QR Pharma CEO weighs in on FDA's proposal for Alzheimer's disease drugs

The Berwyn company's lead new drug candidate targets Alzhemier's and Parkinson's.

Source: bizjournals.com Health Care:Biotechnology headlines - February 21, 2018 Category: Biotechnology Authors: John George Source Type: news